LLY
Eli Lilly and Company
NYQ
$1,081.00
+16.85
(+1.58%)
Extended · +1.40σ
Valuation
Market cap
$964.0B
P/E (ttm)
38.3
Forward P/E
24.3
Beta (5y)
0.48
Shares out
891.7M
Div yield
65.00%
Profitability & returns
ROE
107.5%
Net margin
35.0%
FCF margin
12.7%
Debt / equity
1.39
Trading information
Last price
$1081.00
Day range
$1081.00 – $1081.00
52-wk range
$850.51 – $1149.10
Avg volume
3.1M
RSI (2)
54.0
TAO zone
Extended
Company
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYQ
Next earnings
2026-08-05
Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humu…